Literature DB >> 20702628

Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication.

Ruth L O Stricker1, Sven-Erik Behrens, Egbert Mundt.   

Abstract

Two of the central issues in developing new strategies to interfere with viral infections concern the identification of cellular proteins involved in viral replication and/or antiviral measures and the dissection of the underlying molecular mechanisms. To gain initial insight into the role of host proteins in the life cycle of infectious bursal disease virus (IBDV), a double-stranded RNA virus, we examined the cellular nuclear factor 45 (NF45). NF45 was previously indicated to be involved in the replication process of other types of RNA viruses. Interestingly, by performing immunofluorescence studies, we found that in IBDV-infected cells the mainly nuclear NF45 accumulated at the sites of viral replication in the cytoplasm. NF45 was shown to specifically colocalize with the viral RNA-dependent RNA polymerase VP1, the capsid protein VP2, and the ribonucleoprotein VP3. Immunoprecipitation experiments indicated protein-protein associations between NF45 and VP1, VP2, and VP3. Expression of the individual VP3 or the combination of expression of VP1 and VP3 did not result in a cytoplasmic accumulation of NF45, which, among other data, showed that recruitment of the cellular protein in infected cells functionally correlates with the viral replication process. Since small interfering RNA(siRNA)-mediated downregulation of NF45 resulted in an approximately 5-fold increase of virus yield, our study suggests that NF45, by association with viral proteins, is part of a yet-uncharacterized cellular defense mechanism against IBDV infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702628      PMCID: PMC2950606          DOI: 10.1128/JVI.02506-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR.

Authors:  L R Saunders; D J Perkins; S Balachandran; R Michaels; R Ford; A Mayeda; G N Barber
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

2.  Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein.

Authors:  Pui Wang; Wenjun Song; Bobo Wing-Yee Mok; Pengxi Zhao; Kun Qin; Alexander Lai; Gavin J D Smith; Jinxia Zhang; Tianwei Lin; Yi Guan; Honglin Chen
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

3.  Nucleotide sequence of infectious bursal disease virus genome segment A delineates two major open reading frames.

Authors:  U Spies; H Müller; H Becht
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

4.  Reconstitution of TCP80/NF90 translation inhibition activity in insect cells.

Authors:  Y H Xu; C Busald; G A Grabowski
Journal:  Mol Genet Metab       Date:  2000-06       Impact factor: 4.797

5.  A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus.

Authors:  C Birghan; E Mundt; A E Gorbalenya
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

6.  Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis.

Authors:  K Yao; V N Vakharia
Journal:  Virology       Date:  2001-06-20       Impact factor: 3.616

7.  Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites.

Authors:  N Lejal; B Da Costa; J C Huet; B Delmas
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

8.  VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis.

Authors:  E Lombardo; A Maraver; I Espinosa; A Fernández-Arias; J F Rodriguez
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

9.  Molecular cloning and characterization of a translational inhibitory protein that binds to coding sequences of human acid beta-glucosidase and other mRNAs.

Authors:  Y H Xu; G A Grabowski
Journal:  Mol Genet Metab       Date:  1999-12       Impact factor: 4.797

10.  Nuclear export of influenza virus ribonucleoproteins: identification of an export intermediate at the nuclear periphery.

Authors:  K Ma; A M Roy; G R Whittaker
Journal:  Virology       Date:  2001-04-10       Impact factor: 3.616

View more
  21 in total

1.  NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.

Authors:  Chunhua Wan; Chen Gong; Li Ji; Xiaorong Liu; Yayun Wang; Liang Wang; Mengting Shao; Linlin Yang; Shaoqing Fan; Yin Xiao; Xiaotong Wang; Manhua Li; Guoxiong Zhou; Yixin Zhang
Journal:  Mol Cell Biochem       Date:  2015-08-15       Impact factor: 3.396

2.  The association of receptor of activated protein kinase C 1(RACK1) with infectious bursal disease virus viral protein VP5 and voltage-dependent anion channel 2 (VDAC2) inhibits apoptosis and enhances viral replication.

Authors:  Wencheng Lin; Zhiqiang Zhang; Zhichao Xu; Bin Wang; Xiaoqi Li; Hong Cao; Yongqiang Wang; Shijun J Zheng
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

3.  Epigenetic Upregulation of Chicken MicroRNA-16-5p Expression in DF-1 Cells following Infection with Infectious Bursal Disease Virus (IBDV) Enhances IBDV-Induced Apoptosis and Viral Replication.

Authors:  Xueyan Duan; Mingliang Zhao; Yongqiang Wang; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

4.  Critical role for voltage-dependent anion channel 2 in infectious bursal disease virus-induced apoptosis in host cells via interaction with VP5.

Authors:  Zhonghua Li; Yongqiang Wang; Yanfei Xue; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  MicroRNA gga-miR-130b Suppresses Infectious Bursal Disease Virus Replication via Targeting of the Viral Genome and Cellular Suppressors of Cytokine Signaling 5.

Authors:  Mengjiao Fu; Bin Wang; Xiang Chen; Zhiyuan He; Yongqiang Wang; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

6.  Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.

Authors:  Tingting Ni; Guoxin Mao; Qun Xue; Yifei Liu; Buyou Chen; Xuefan Cui; Liting Lv; Liangliang Jia; Yuchan Wang; Lili Ji
Journal:  J Mol Histol       Date:  2015-06-10       Impact factor: 2.611

7.  Critical roles of glucocorticoid-induced leucine zipper in infectious bursal disease virus (IBDV)-induced suppression of type I Interferon expression and enhancement of IBDV growth in host cells via interaction with VP4.

Authors:  Zhonghua Li; Yongqiang Wang; Xiang Li; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

8.  Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC).

Authors:  Sujie Ni; Junya Zhu; Jianguo Zhang; Shu Zhang; Mei Li; Runzhou Ni; Jinxia Liu; Huiyuan Qiu; Wenjuan Chen; Huijie Wang; Weijian Guo
Journal:  Tumour Biol       Date:  2014-10-08

9.  Cyclophilin A Interacts with Viral VP4 and Inhibits the Replication of Infectious Bursal Disease Virus.

Authors:  Nian Wang; Lizhou Zhang; Yuming Chen; Zhen Lu; Li Gao; Yongqiang Wang; Yulong Gao; Honglei Gao; Hongyu Cui; Kai Li; Changjun Liu; Yanping Zhang; Xiaole Qi; Xiaomei Wang
Journal:  Biomed Res Int       Date:  2015-05-24       Impact factor: 3.411

10.  Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.

Authors:  R A Shamanna; M Hoque; T Pe'ery; M B Mathews
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.